Currently out of the existing stock ratings of Reuben Garner, 138 are a BUY (94.52%), 8 are a HOLD (5.48%).

Reuben Garner

Work Performance Price Targets & Ratings Chart

Analyst Reuben Garner, currently employed at BENCHMARK, carries an average stock price target met ratio of 55.33% that have a potential upside of 27.87% achieved within 173 days.

Reuben Garner’s has documented 275 price targets and ratings displayed on 29 stocks. The coverage is on Industrials, Basic Materials, Consumer Cyclical, Healthcare sectors.

Most recent stock forecast was given on BLD, Topbuild Corp at 05-Aug-2025.

Wall Street Analyst Reuben Garner

Analyst best performing recommendations are on LABP (LANDOS BIOPHARMA).
The best stock recommendation documented was for BDC (BELDEN) at 11/1/2024. The price target of $130 was fulfilled within 5 days with a profit of $14.96 (13%) receiving and performance score of 26.01.

Average potential price target upside

of $79 (62.15%) on LABP (LANDOS BIOPHARMA).
of $43.59 (16.65%) on BLD (TOPBUILD CORP).
of $29.25 (45.56%) on BXC (BLUELINX HOLDINGS).

BLD Topbuild Corp BLDR Builders FirstSource BXC BlueLinx Holdings IBP Installed Building Products JBI Janus International Group OC Owens Corning SCS Steelcase TREX Trex Company UFPI Ufp Industries DOOR Masonite International Corp MLHR Herman Miller BCC Boise Cascad Llc FGI FGI Industries Ltd AVDL Avadel Pharmaceuticals PLC BDC Belden CSTE Caesarstone Ltd CUE Cue Biopharma FENC Fennec Pharmaceuticals JELD Jeld-Wen KBAL Kimball International LABP Landos Biopharma MLKN MillerKnoll NX Quanex Building Products HNI HNI Corp HLMN Hillman Solutions Corp XERS Xeris Pharmaceuticals AZEK Azek Company BECN Beacon Roofing Supply BMCH BMC Stock Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Stephen Kim (EVERCORE)